Safety and tolerability of PD-1/PD-L1 inhibitors in elderly and frail patients with advanced malignancies.
Sakakida T, Ishikawa T, Uchino J, Tabuchi Y, Komori S, Asai J, Arai A, Tsunezuka H, Kosuga T, Konishi H, Hongo F, Inoue M, Hirano S, Ukimura O, Taguchi T, Takayama K, Itoh Y.
Sakakida T, et al. Among authors: hirano s.
Oncol Lett. 2020 Oct;20(4):14. doi: 10.3892/ol.2020.11875. Epub 2020 Jul 15.
Oncol Lett. 2020.
PMID: 32774487
Free PMC article.